EMG
TXG icon

ETF Managers Group’s 10x Genomics TXG Stock Holding History

ETF Managers Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$238K Buy
+4,258
New +$199K 0.01% 566
2021
Q3 		– Sell
-9,463
Closed -$1.91M – 722
2021
Q2 		$1.91M Buy
+9,463
New +$1.71M 0.03% 225

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SIM
SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

ETF Managers Group's TXG Position: Q1 2023 in Review

ETF Managers Group opened a new position in 10x Genomics (TXG) in Q1 2023: 4,258 shares worth $238K. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in TXG as recently as Q2 2021.

ETF Managers Group first reported a position in TXG in Q2 2021 and has held it in 2 quarters since. The position peaked at $1.91M in Q2 2021. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

  • ETF Managers Group held 4,258 shares of 10x Genomics worth $238K as of Q1 2023.
  • 10x Genomics was a new ETF Managers Group position in Q1 2023.
  • 10x Genomics made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #566 holding.
  • ETF Managers Group first reported a position in 10x Genomics in Q2 2021 and has held it in 2 quarters since.
  • ETF Managers Group's 10x Genomics position peaked at $1.91M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.